QUINOLINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO THE MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR
申请人:Abbvie Deutschland GmbH & Co. KG
公开号:US20170260158A1
公开(公告)日:2017-09-14
The present invention relates to quinoline compounds of formula I
wherein the variables are defined as in the claims and the description. The invention further relates to a pharmaceutical composition containing such compounds, to their use as modulators of the 5-HT
6
receptor, their use for preparing a medicament for the prevention or treatment of conditions and disorders which respond to the modulation of the 5-HT
6
receptor, and to methods for preventing or treating conditions and disorders which respond to the modulation of the 5-HT
6
receptor.
本发明涉及公式I的喹啉化合物,其中变量的定义如索引和描述中所述。本发明还涉及含有这种化合物的药物组合物,以及它们作为5-HT6受体调节剂的用途,用于制备用于预防或治疗对5-HT6受体调节有反应的疾病和疾病的药物,以及用于预防或治疗对5-HT6受体调节有反应的疾病和疾病的方法。